The potentiating effect of LPS on tumor necrosis factor-alpha production by influenza A virus-infected macrophages

Related Experiment Videos

A Bender1, H Sprenger, J H Gong

  • 1Institute of Immunology, Philipps University, Marburg, Germany.

Immunobiology
|April 1, 1993
PubMed

Insights

Influenza A virus infection potentiates tumor necrosis factor-alpha (TNF-alpha) production in macrophages when combined with lipopolysaccharide (LPS). This enhanced TNF-alpha release may explain severe complications in co-infections.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Influenza A virus infection in macrophages leads to cell death via tumor necrosis factor-alpha (TNF-alpha) release.
  • Lipopolysaccharide (LPS) can enhance TNF-alpha production, but its interaction with viral infections is complex.

Purpose of the Study:

  • To investigate the combined effect of influenza A virus infection and LPS on TNF-alpha production in macrophages.
  • To elucidate the mechanisms underlying enhanced TNF-alpha release in co-infected cells.

Main Methods:

  • Infection of murine PU5-1.8 macrophages and human monocytes with influenza A virus.
  • Treatment of infected cells with varying concentrations of LPS or lipid A.
  • Measurement of TNF-alpha production, mRNA levels, and protein translation.

Main Results:

  • Influenza A virus infection alone caused significant TNF-alpha mRNA accumulation but limited protein translation.
  • Low concentrations of LPS strongly potentiated TNF-alpha protein release from virus-infected macrophages.
  • Enhanced TNF-alpha production was not due to increased cell survival, altered virus replication, or changes in gene transcription or secretion kinetics.

Conclusions:

  • Influenza A virus primes macrophages for enhanced TNF-alpha protein synthesis upon subsequent LPS exposure.
  • The findings suggest that excessive TNF-alpha release in combined viral and bacterial infections contributes to severe clinical complications.

Related Concept Videos